Search results
Is Eli Lilly Stock A Buy After Weight-Loss Drug Crushes Quarterly Sales Forecasts?
Investor's Business Daily· 19 minutes agoSales of generics-facing Alimta, a cancer drug, are also forecast to drop. Eli Lilly Stock Analysis...
AMPH- A Generic Drugmaker Looking to Expand Via Acquisition, Biosimilars Moves
MoneyShow via Yahoo Finance· 6 days agoAmphastar Pharmaceuticals Inc. (AMPH) is a generic drug company founded in 1996 that went public in 2014. Amphastar focuses on drugs ...
Bristol Myers to cut 6% of workforce, trim drug pipeline
BioPharma Dive via Yahoo Finance· 5 days agoBristol Myers’ cuts come after a first quarter during which several of its prized new medicines...
Weight loss drugs like Wegovy have taken the country by storm. But who can afford them?
USA TODAY via Yahoo Finance· 5 days agoDrugmakers say they price...development costs. They often also must pay lucrative rebates to drug...
Mark Cuban has a simple question for CVS’s drug middleman: Why don’t you publish your prices?
Ohio Capital Journal via Yahoo News· 4 days agoBusinessman and TV personality Mark Cuban has a seemingly straightforward question for the huge drug...
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks via Yahoo Finance· 6 days agoDrug and biotech companies are likely to see significant innovation. In the Large-Cap...
Biogen (BIIB) Q1 Earnings Beat, Stock Up on Alzheimer Drug Uptake
Zacks via Yahoo Finance· 6 days agoBiogen's (BIIB) first-quarter earnings beat estimates but sales miss the mark. While sales of key...
Is Bristol Myers Squibb Stock a Millionaire Maker?
Motley Fool via Yahoo Finance· 5 days agoRevenue fell by 3% last year to just over $45 billion, the second straight year that the top line has declined. The concern is that it could be the start...
BioMarin stock falls 9% in wake of Q1 report, pipeline updates
Seeking Alpha· 5 days agoBioMarin (BMRN) stock fell 9% Thursday, the day after the company released its Q1 earnings report...
State gets opioid-reversal drugs at big discount
The San Francisco Examiner· 18 hours agoCalifornia is partnering with a New Jersey-based pharmaceutical company to distribute more than 3 million twin-packs of opioid-reversal drugs across the...